Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARCT trades at $6.95 with a market cap of $199.81M and a P/E ratio of -2.40. ARCT moved +1.94% today. Year to date, ARCT is +7.06%; over the trailing twelve months it is -46.30%. Its 52-week range spans $5.85 to $25.88. Analyst consensus is buy with an average price target of $18.50. Rallies surfaces ARCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARCT moved +1.94% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $6.95 |
| Market Cap | $199.81M |
| P/E Ratio | -2.40 |
| EPS | $-2.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.88 |
| 52-Week Low | $5.85 |
| Volume | 392.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $54.71M |
| Net Income | $-78.67M |
| Gross Margin | 0.00% |
10 analysts cover ARCT: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $18.50.